Health Care
(E80)
990 on File
HOUSE OF TRANSPLANT & CANCER
Financial strength (30%)
69/100
Reliability (20%)
45/100
Effectiveness (25%)
63/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$1.0M
Total Revenue
$1.3M
Total Expenses
$295K
Net Assets
26
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
90.0%
Fundraising Efficiency
N/A
Operating Reserve
2.76x
Liability-to-Asset
0.2%
Revenue Diversification
101.8%
Executive Compensation
$0
Compared with Peers
FY 2023
Compared with 4,434 similar organizations
(United States, Health Care, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
90.0% | 84.9% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.0% | 11.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
2.8 mo | 9.7 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.2% | 14.7% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
101.8% | 91.3% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-8.3% | 5.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
9.8% | 9.2% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-25.0% | 1.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $1.0M | $1.3M | $295K | 90.0% | 26 |
| 2022 | $1.1M | $1.2M | $402K | 90.0% | 23 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.